pI: 10.5637 |
Length (AA): 100 |
MW (Da): 10978 |
Paralog Number:
1
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There is 1 model calculated for this protein. More info on
this model, including the
model itself is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
21 | 100 | 4yvd (A) | 190 | 269 | 53.00 | 0.00000011 | 0.87 | 1.3887 | 0.16 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Ortholog group members (OG5_128222)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT4G15900 | protein pleiotropic regulatory locus 1 |
Arabidopsis thaliana | AT3G16650 | protein pleiotropic regulator PRL2 |
Babesia bovis | BBOV_III007650 | WD domain, G-beta repeat containing protein |
Brugia malayi | Bm1_28715 | Pre-mRNA splicing protein prp5 |
Candida albicans | CaO19.5413 | WD40 repeat protein similar to S. cerevisiae PRP46 (YPL151C) spliceosome subcomplex Cwc/Ntc component |
Candida albicans | CaO19.12868 | WD40 repeat protein similar to S. cerevisiae PRP46 (YPL151C) spliceosome subcomplex Cwc/Ntc component |
Caenorhabditis elegans | CELE_D1054.15 | Protein PLRG-1, isoform B |
Cryptosporidium hominis | Chro.70442 | pleiotropic regulator 1 |
Cryptosporidium parvum | cgd7_3960 | pleiotropic regulator 1 |
Dictyostelium discoideum | DDB_G0279507 | WD40 repeat-containing protein |
Drosophila melanogaster | Dmel_CG1796 | Transport and Golgi organization 4 |
Echinococcus granulosus | EgrG_000570200 | pleiotropic regulator 1 |
Entamoeba histolytica | EHI_153530 | pre-mRNA-splicing factor PRP46, putative |
Echinococcus multilocularis | EmuJ_000008500 | pleiotropic regulator 1 |
Echinococcus multilocularis | EmuJ_000570200 | pleiotropic regulator 1 |
Homo sapiens | ENSG00000171566 | pleiotropic regulator 1 |
Leishmania braziliensis | LbrM.35.5070 | hypothetical protein, conserved |
Leishmania donovani | LdBPK_365050.1 | WD domain, G-beta repeat, putative |
Leishmania infantum | LinJ.36.5050 | hypothetical protein, conserved |
Leishmania major | LmjF.36.4820 | hypothetical protein, conserved |
Leishmania mexicana | LmxM.36.4820 | hypothetical protein, conserved |
Loa Loa (eye worm) | LOAG_06522 | hypothetical protein |
Loa Loa (eye worm) | LOAG_06521 | hypothetical protein |
Mus musculus | ENSMUSG00000027998 | pleiotropic regulator 1, PRL1 homolog (Arabidopsis) |
Neospora caninum | NCLIV_061820 | Testis cDNA clone: QtsA-14439, similar to human pleiotropic regulator 1 (PRL1homolog, Arabidopsis)(PLRG1),, related |
Oryza sativa | 4332781 | Os03g0339100 |
Onchocerca volvulus | OVOC10181 |
|
Onchocerca volvulus | OVOC11498 |
|
Onchocerca volvulus | OVOC5149 |
|
Plasmodium berghei | PBANKA_0401000 | pre-mRNA-splicing factor PRP46, putative |
Plasmodium falciparum | PF3D7_0302000 | pre-mRNA-splicing factor PRP46, putative |
Plasmodium knowlesi | PKNH_0840700 | pre-mRNA-splicing factor PRP46, putative |
Plasmodium vivax | PVX_119245 | splicing regulatory protein, putative |
Plasmodium yoelii | PY07385 | Plasmodium vivax PV1H14040_P |
Saccharomyces cerevisiae | YPL151C | Prp46p |
Schistosoma japonicum | Sjp_0072620 | Pleiotropic regulator 1, putative |
Schistosoma mansoni | Smp_104870 | hypothetical protein |
Trypanosoma brucei gambiense | Tbg972.10.12420 | hypothetical protein, conserved |
Trypanosoma brucei | Tb927.10.10170 | pre-mRNA splicing factor 46, putative |
Trypanosoma congolense | TcIL3000_10_8240 | predicted WD40 repeat protein |
Trypanosoma cruzi | TcCLB.508307.44 | pre-mRNA splicing factor 46, putative |
Toxoplasma gondii | TGME49_218420 | WD domain, G-beta repeat-containing protein |
Theileria parva | TP04_0666 | hypothetical protein, conserved |
Trichomonas vaginalis | TVAG_122280 | WD-repeat protein, putative |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb927.10.10170 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (3 days) | alsford |
Tb927.10.10170 | Trypanosoma brucei | significant loss of fitness in bloodstream forms (6 days) | alsford |
Tb927.10.10170 | Trypanosoma brucei | significant gain of fitness in procyclic forms | alsford |
Tb927.10.10170 | Trypanosoma brucei | significant loss of fitness in differentiation of procyclic to bloodstream forms | alsford |
CELE_D1054.15 | Caenorhabditis elegans | embryonic lethal | wormbase |
CELE_D1054.15 | Caenorhabditis elegans | larval arrest | wormbase |
CELE_D1054.15 | Caenorhabditis elegans | larval lethal | wormbase |
CELE_D1054.15 | Caenorhabditis elegans | sterile | wormbase |
YPL151C | Saccharomyces cerevisiae | inviable | yeastgenome |
TGME49_218420 | Toxoplasma gondii | Probably essential | sidik |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.